NKT cell adjuvant-based tumor vaccine for treatment of myc oncogene-driven mouse B-cell lymphoma
Stephen R Mattarollo, Alison C West, Kim Steegh, Helene Duret, Christophe Paget, Ben Martin, Geoffrey M Matthews, Jake Shortt, Marta Chesi, P Leif Bergsagel, Michael Bots, Johannes Zuber, Scott W Lowe, Ricky W Johnstone, Mark J Smyth
Blood | AMER SOC HEMATOLOGY | Published : 2012
This work was supported by the National Health and Medical Research Council of Australia (program grant). S.R.M. was supported by a Balzan Foundation Fellowship. M.J.S. was supported by a National Health and Medical Research Council of Australia Fellowship.